Elektrofi

Elektrofi is a biotechnology company revolutionizing the delivery of biologic therapies. Their innovative ultra-high concentration microparticle technology platform, Hypercon™, enables convenient at-home subcutaneous self-administration, eliminating the need for traditional intravenous therapies. This groundbreaking approach focuses on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, empowering patients to control their treatment experience and enhancing their overall well-being.

Elektrofi thrives on strategic partnerships with leading pharmaceutical companies, enabling them to jointly develop and commercialize subcutaneous biologic therapies. Driven by a patient-centered approach, they aim to transform the way patients receive life-changing medicines, improving access and creating a healthier world. Their commitment to innovation is reflected in their team of MIT engineers and scientists who are shaping the future of biologics delivery.

Elektrofi explicitly emphasizes an in-office work environment as a core aspect of their company culture, encouraging a collaborative and hands-on approach to innovation. While remote work is acknowledged as potentially beneficial, it's not a fundamental part of their working approach. To support employees who commute to the office, they offer a commuter assistance program providing up to $315 per month. This information suggests that flexibility is limited in terms of remote work, with a clear preference for in-office collaboration.

Elektrofi offers a comprehensive benefits package designed to support employees' well-being and financial security. These benefits include medical, vision, and dental insurance, as well as a 401(k) plan, paid parental leave, and disability insurance. The company also provides commuter benefits, offering employees financial assistance of up to $315 per month to help offset the costs of transportation.

Elektrofi is a biopharmaceutical formulation technology company dedicated to revolutionizing the delivery of biologic therapies. Through their innovative ultra-high concentration microparticle platform, Hypercon™, Elektrofi aims to eliminate the limitations associated with traditional intravenous biologic therapies, enabling convenient at-home subcutaneous self-administration of life-changing medicines. By collaborating with strategic partners, Elektrofi strives to create, develop, and commercialize subcutaneous biologic therapies that empower patients with greater control over their treatment experience and contribute to a healthier world.

Elektrofi cultivates a collaborative and innovative culture that values curiosity, diverse perspectives, and a relentless pursuit of solutions. They encourage their team members to challenge conventional approaches and embrace a "Why not?" mentality, fostering a supportive and open environment where everyone feels empowered to contribute their unique ideas and experiences. This dynamic atmosphere is further enhanced by their commitment to an in-office work ethos, recognizing the value of face-to-face interaction and fostering a sense of community amongst employees.

Elektrofi values curiosity, diversity in thought and experiences, and collaboration, believing that these aspects are key to innovation and success. The company actively seeks a diverse workforce and fosters an inclusive environment where everyone feels valued and respected. They explicitly state in job postings that they provide equal employment opportunities and prohibit discrimination or harassment based on protected characteristics.